303 related articles for article (PubMed ID: 20959785)
1. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
[TBL] [Abstract][Full Text] [Related]
2. Drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction: What does the crystal ball tell you?
Auer J; Lamm G
Crit Care Med; 2011 Jan; 39(1):204-5. PubMed ID: 21178539
[No Abstract] [Full Text] [Related]
3. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
Yap YG; Camm AJ
Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators.
Alexander JH; Granger CB; Sadowski Z; Aylward PE; White HD; Thompson TD; Califf RM; Topol EJ
Am Heart J; 1999 May; 137(5):799-805. PubMed ID: 10220627
[TBL] [Abstract][Full Text] [Related]
5. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
[TBL] [Abstract][Full Text] [Related]
7. Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation.
Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
Am J Cardiol; 1999 Nov; 84(9A):46R-51R. PubMed ID: 10568659
[TBL] [Abstract][Full Text] [Related]
8. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Cairns JA; Connolly SJ; Roberts R; Gent M
Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
[TBL] [Abstract][Full Text] [Related]
9. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
Rea RS; Kane-Gill SL; Rudis MI; Seybert AL; Oyen LJ; Ou NN; Stauss JL; Kirisci L; Idrees U; Henderson SO
Crit Care Med; 2006 Jun; 34(6):1617-23. PubMed ID: 16614583
[TBL] [Abstract][Full Text] [Related]
10. Mortality reduction by antiadrenergic modulation of arrhythmogenic substrate: significance of combining beta blockers and amiodarone.
Ogunyankin KO; Singh BN
Am J Cardiol; 1999 Nov; 84(9A):76R-82R. PubMed ID: 10568664
[TBL] [Abstract][Full Text] [Related]
11. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
[TBL] [Abstract][Full Text] [Related]
12. Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
Viskin S; Chorin E; Viskin D; Hochstadt A; Halkin A; Tovia-Brodie O; Lee JK; Asher E; Laish-Farkash A; Amit G; Havakuk O; Belhassen B; Rosso R
Circulation; 2019 May; 139(20):2304-2314. PubMed ID: 30696267
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
Proclemer A; Facchin D; Vanuzzo D; Feruglio GA
Cardiovasc Drugs Ther; 1993 Aug; 7(4):683-9. PubMed ID: 8241012
[TBL] [Abstract][Full Text] [Related]
14. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
Al-Khatib SM; Granger CB; Huang Y; Lee KL; Califf RM; Simoons ML; Armstrong PW; Van de Werf F; White HD; Simes RJ; Moliterno DJ; Topol EJ; Harrington RA
Circulation; 2002 Jul; 106(3):309-12. PubMed ID: 12119245
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone: maximising survival benefit with empiric or guided therapy.
Steinbeck G; Dorwarth U; Hoffmann E
J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():51-5. PubMed ID: 10590489
[TBL] [Abstract][Full Text] [Related]
16. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
Yusu S; Ikeda T; Mera H; Miyakoshi M; Miwa Y; Abe A; Tsukada T; Ishiguro H; Shimizu H; Yoshino H
Circ J; 2009 Nov; 73(11):2021-8. PubMed ID: 19724153
[TBL] [Abstract][Full Text] [Related]
19. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.
Al-Khatib SM; Stebbins AL; Califf RM; Lee KL; Granger CB; White HD; Armstrong PW; Topol EJ; Ohman EM;
Am Heart J; 2003 Mar; 145(3):515-21. PubMed ID: 12660676
[TBL] [Abstract][Full Text] [Related]
20. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
